levocabastine has been researched along with raclopride in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukui, R; Higashi, H; Matsuyama, S; Nishi, A | 1 |
Ohinata, K; Yamauchi, R; Yoshikawa, M | 1 |
2 other study(ies) available for levocabastine and raclopride
Article | Year |
---|---|
Regulation of DARPP-32 Thr75 phosphorylation by neurotensin in neostriatal neurons: involvement of glutamate signalling.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Anesthetics, Local; Animals; Benzazepines; Dizocilpine Maleate; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Glutamic Acid; Histamine H1 Antagonists; Immunoblotting; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Neostriatum; Nerve Tissue Proteins; Neurons; Neurotensin; Phosphoproteins; Piperidines; Pyrazoles; Quinolines; Raclopride; Receptors, Neurotensin; Signal Transduction; Tetrodotoxin; Threonine; Time Factors | 2003 |
Beta-lactotensin and neurotensin rapidly reduce serum cholesterol via NT2 receptor.
Topics: Animals; Cholesterol; Dopamine Antagonists; Male; Mice; Mice, Inbred ICR; Neurotensin; Oligopeptides; Piperidines; Raclopride; Receptors, Neurotensin | 2003 |